BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1797190)

  • 1. Ifosfamide in pediatric oncology.
    de Kraker J
    Anticancer Drugs; 1991 Aug; 2(4):339-41. PubMed ID: 1797190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide in pediatric oncology.
    Voûte PA; de Kraker J
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):2-6. PubMed ID: 1411617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current studies of ifosfamide for pediatric solid tumors and leukemia in the United States.
    Pratt CB
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):43-9. PubMed ID: 1485174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP).
    Chastagner P; Sommelet-Olive D; Kalifa C; Brunat-Mentigny M; Zucker JM; Demeocq F; Baranzelli MC; Tron P; Bergeron C; Pein F
    Med Pediatr Oncol; 1993; 21(1):49-53. PubMed ID: 8381203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
    Pratt CB; Douglass EC; Etcubanas E; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):51-5. PubMed ID: 2495567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376).
    Geller JI; Wall D; Perentesis J; Blaney SM; Bernstein M;
    Pediatr Blood Cancer; 2009 Mar; 52(3):346-50. PubMed ID: 18989889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide in pediatric malignant solid tumors.
    Pratt CB; Douglass EC; Etcubanas EL; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S24-7. PubMed ID: 2503257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study.
    Heideman RL; Douglass EC; Langston JA; Krischer JP; Burger PC; Kovnar EH; Kun LE; Friedman HS; Kadota R
    J Neurooncol; 1995; 25(1):77-84. PubMed ID: 8523093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors.
    Saito Y; Kumamoto T; Makino Y; Tamai I; Ogawa C; Terakado H
    Jpn J Clin Oncol; 2016 Sep; 46(9):856-61. PubMed ID: 27380806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephropathy in patients treated with ifosfamide].
    Kiss K; Nagy K; Hunyadi K; Simkó R
    Orv Hetil; 1994 May; 135(19):1023-6. PubMed ID: 8183542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric Oncology.
    Tournade MF; Lemerle J; Brunat-Mentigny M; Bachelot C; Roche H; Taboureau O; Olive D; Lejars O; Boilletot A; Demeocq F
    J Clin Oncol; 1988 May; 6(5):793-6. PubMed ID: 2835442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with ifosfamide in paediatric tumours.
    de Kraker J; Voûte PA
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S28-9. PubMed ID: 2758568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil.
    Loss JF; Santos PP; Leone LD; Brunetto AL
    Pediatr Blood Cancer; 2004 Feb; 42(2):139-44. PubMed ID: 14752877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide in paediatric oncology: tried but not tested?
    Shaw PJ; Eden T
    Lancet; 1990 Apr; 335(8696):1022-3. PubMed ID: 1970073
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide for children with solid tumours.
    Lancet; 1990 Jun; 335(8702):1398-400. PubMed ID: 1971676
    [No Abstract]   [Full Text] [Related]  

  • 17. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
    Oberlin O; Habrand JL; Zucker JM; Brunat-Mentigny M; Terrier-Lacombe MJ; Dubousset J; Gentet JC; Schmitt C; Ponvert D; Carrié C
    J Clin Oncol; 1992 Sep; 10(9):1407-12. PubMed ID: 1517783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide in pediatric solid tumors.
    Carli M; Passone E; Perilongo G; Bisogno G
    Oncology; 2003; 65 Suppl 2():99-104. PubMed ID: 14586158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rickets--a complication of ifosfamide chemotherapy for Wilms tumor.
    Relf M; Boal DK
    Pediatr Radiol; 1992; 22(3):209-10. PubMed ID: 1324461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ifosfamide in paediatric cancer.
    Advani SH
    Aust N Z J Med; 1998 Jun; 28(3):410-3. PubMed ID: 9673760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.